The World Health Organization as approved the first diagnostic test for mpox, previously known as monkeypox.
This is a significant step for countries battling outbreaks, especially in Africa, where more than 800 people have died from the virus, which has been confirmed in 16 countries.
In a statement, the WHO described the approval for emergency use of the new test as “pivotal” for improving diagnostic capacity in affected areas. The test, called the Alinity m MPXV assay, is made by Abbott Molecular Inc. It detects the mpox virus from swab samples taken from skin lesions, which helps health workers confirm cases quickly and accurately.
“Limited testing capacity and delays in confirming mpox cases persist in Africa, contributing to the continued spread of the virus,” the WHO said, emphasizing the importance of the new test. The organization’s Assistant Director-General Yukiko Nakatani said, “Increasing access to quality-assured medical products is central to our efforts in assisting countries to contain the spread of the virus and protect their people, especially in underserved regions.”
Mpox is transmitted to humans through contact with infected animals or by close physical contact between people. Symptoms include fever, muscle aches, and large skin lesions, which can be deadly.
